Liver Carcinoma clinical trials in Florida
13 active Liver Carcinoma trials with a site in Florida. Describe your situation to see which ones you may be eligible for.
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
- Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
- A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- A Prospective, Single-Center Investigation of the da Vinci SPĀ® Surgical System in Hepatopancreaticobiliary and Foregut Operations for Benign and Malignant Disease
- Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- DESTINY-PANTUMOUR04
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Integrated Cancer Repository for Cancer Research
- RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- A Study of CS231295 in Patients With Advanced Solid Tumors
- Wet Heparinized Suction for Abdominal Cancer
- Testing Alcohol Cancer Risk Messages
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down ā and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest ā what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.